| 摘要 |
A nootropic composition possessing the anticholinesterase activity and restoring the neuromuscular transmission comprises the active ingredient, namely 9-butylamino-3,3-dimethyl-3,4-dihydro(2H)acridine-1-ОН hydrochloride (bucridon hydrochloride) and the pharmacologically acceptable base. The dose of the active ingredient amounts to 0.005-0.06 mg. |
